米国における薬用スキンケア市場

Abstract

• Euromonitor International' s Medicated Skin Care in the US report offers a comprehensive guide to the size and shape of the market at a national level.
• It provides the latest retail sales data (2002-2007), allowing you to identify the sectors driving growth.
• It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues.
• Forecasts to 2012 illustrate how the market is set to change.
• Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments
• Data coverage: market sizes (historic and forecasts), company shares and brand shares
• Why buy this report?
  • Get a detailed picture of the medicated skin care industry
  • Identify factors driving change
  • Understand the competitive environment, the market' s major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop
• Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems.
• With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN THE US
• Executive Summary
• OTC Industry Remains Innovative
• Behind-the-counter Category Emerges
• Johnson & Johnson Continues To Lead the Industry
• Retailers Focus on Consumer Health
• Economic Downturn Contributes To Industry Growth
• Key Trends and Developments
• Consumers Self-medicate
• Ageing Population Demands High Quality of Life
• Leading Players Growth Through Consolidation
• Behind-the-counter Category Emerges
• Product Safety Concerns Erode Confidence in Manufacturers and FDA
• Market Indicators
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
  • Table 2 Life Expectancy at Birth 2002-2007
• Market Data
  • Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
  • Table 5 OTC Healthcare Company Shares by Value 2003-2007
  • Table 6 OTC Healthcare Brand Shares by Value 2004-2007
  • Table 7 Penetration of Private Label by Sector 2003-2007
  • Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
  • Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
  • Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
  • Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
• Appendix
• OTC Registration and Classification
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Switches
  • Summary 1 OTC Healthcare Switches 2006-2008
• Definitions
  • Summary 2 Research Sources
• LOCAL COMPANY PROFILES - USA
• Adams Respiratory Therapeutics Inc
• Strategic Direction
• Key Facts
  • Summary 3 Adams Respiratory Therapeutics Inc: Key Facts
  • Summary 4 Adams Respiratory Therapeutics Inc: Operational Indicators 2005-2007
• Company Background
• Production
• Competitive Positioning
  • Summary 5 Adams Respiratory Therapeutics Inc: Competitive Position 2007
• Chattem Inc
• Strategic Direction
• Key Facts
  • Summary 6 Chattem Inc: Key Facts
  • Summary 7 Chattem Inc: Operational Indicators 2005-2007
• Company Background
• Production
• Competitive Positioning
  • Summary 8 Chattem Inc: Competitive Position 2007
• General Nutrition Centers Inc
• Strategic Direction
• Key Facts
  • Summary 9 General Nutrition Centers Inc: Key Facts
  • Summary 10 General Nutrition Centers Inc: Operational Indicators 2005-2007
• Company Background
• Production
• Competitive Positioning
  • Summary 11 General Nutrition Centers: Competitive Position 2007
• Mannatech Inc
• Strategic Direction
• Key Facts
  • Summary 12 Mannatech Inc: Key Facts
  • Summary 13 Mannatech Inc: Operational Indicators 2005-2007
• Company Background
• Production
• Competitive Positioning
  • Summary 14 Mannatech Inc: Competitive Position 2007
• Mcneil Consumer & Specialty Pharmaceuticals
• Strategic Direction
• Key Facts
  • Summary 15 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 16 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2007
• Melaleuca Inc
• Strategic Direction
• Key Facts
  • Summary 17 Mannatech Inc: Key Facts
  • Summary 18 Melaleuca Inc: Operational Indicators 2005-2007
• Company Background
• Production
• Competitive Positioning
  • Summary 19 Melaleuca Inc: Competitive Position 2007
• Nbty Inc
• Strategic Direction
• Key Facts
  • Summary 20 NBTY Inc: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 21 NBTY: Competitive Position 2007
• Procter & Gamble Co, the
• Strategic Direction
• Key Facts
  • Summary 22 Procter & Gamble Co, The: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 23 Procter & Gamble Co, The: Competitive Position 2007
• Wyeth Consumer Healthcare Inc
• Strategic Direction
• Key Facts
  • Summary 24 Wyeth Consumer Healthcare Inc: Key Facts
  • Summary 25 Wyeth Consumer Healthcare Inc: Operational Indicators 2005-2007
• Company Background
• Production
• Competitive Positioning
  • Summary 26 Wyeth Consumer Healthcare Inc: Competitive Position 2007
• MEDICATED SKIN CARE IN THE US
• Headlines
• Trends
• Switches
• Competitive Landscape
• Prospects
• Sector Data
  • Table 12 Sales of Medicated Skin Care by Subsector: Value 2002-2007
  • Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007
  • Table 14 Herbal vs Standard Medicated Skin Care 2002-2007
  • Table 15 Acne Treatments by Format: % Value Breakdown 2004-2007
  • Table 16 Medicated Skin Care Company Shares by Value 2003-2007
  • Table 17 Medicated Skin Care Brand Shares by Value 2004-2007
  • Table 18 Acne Treatments Brand Shares by Value 2004-2007
  • Table 19 Hair Loss Treatments Brand Shares by Value 2004-2007
  • Table 20 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012
  • Table 21 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012
• Medicated skin care USA